131 related articles for article (PubMed ID: 24752085)
21. Periprocedural anticoagulation for atrial fibrillation ablation.
Mortada ME; Chandrasekaran K; Nangia V; Dhala A; Blanck Z; Cooley R; Bhatia A; Gilbert C; Akhtar M; Sra J
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):362-6. PubMed ID: 18284509
[TBL] [Abstract][Full Text] [Related]
22. Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation.
Kwak JJ; Pak HN; Jang JK; Kim SK; Park JH; Choi JI; Hwang C; Kim YH
J Cardiovasc Electrophysiol; 2010 Jun; 21(6):620-5. PubMed ID: 20039992
[TBL] [Abstract][Full Text] [Related]
23. 'The role of novel oral anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation'.
Baltogiannis G; Chierchia GB; Conte G; Sieira J; Di Giovanni G; Ciconte G; de Asmundis C; Saitoh Y; Wauters K; Irfan G; Brugada P
Hellenic J Cardiol; 2016; 57(5):331-337. PubMed ID: 28087311
[TBL] [Abstract][Full Text] [Related]
24. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
Di Biase L; Lakkireddy D; Trivedi C; Deneke T; Martinek M; Mohanty S; Mohanty P; Prakash S; Bai R; Reddy M; Gianni C; Horton R; Bailey S; Sigmund E; Derndorfer M; Schade A; Mueller P; Szoelloes A; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Hongo RH; Beheiry S; Pürerfellner H; Burkhardt JD; Natale A
Heart Rhythm; 2015 Jun; 12(6):1162-8. PubMed ID: 25728754
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
26. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
Weiss A; Brose S; Ploetze K; Matschke K
Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
[TBL] [Abstract][Full Text] [Related]
27. Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
Szummer K; Oldgren J; Lindhagen L; Carrero JJ; Evans M; Spaak J; Edfors R; Jacobson SH; Andell P; Wallentin L; Jernberg T
JAMA; 2015 Feb; 313(7):707-16. PubMed ID: 25688782
[TBL] [Abstract][Full Text] [Related]
28. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
[TBL] [Abstract][Full Text] [Related]
29. SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study.
Cohen A; Stellbrink C; Le Heuzey JY; Faber T; Aliot E; Banik N; Kropff S; Omran H;
Arch Cardiovasc Dis; 2015 Feb; 108(2):122-31. PubMed ID: 25684570
[TBL] [Abstract][Full Text] [Related]
30. Safety of novel oral anticoagulants in catheter ablation of atrial fibrillation.
Hansen PS; Sanchez R; Walfridsson H
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836793
[TBL] [Abstract][Full Text] [Related]
31. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.
Shurrab M; Morillo CA; Schulman S; Kansal N; Danon A; Newman D; Lashevsky I; Healey JS; Crystal E
Can J Cardiol; 2013 Oct; 29(10):1203-10. PubMed ID: 23993352
[TBL] [Abstract][Full Text] [Related]
33. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
[TBL] [Abstract][Full Text] [Related]
34. The use of anticoagulation during the periprocedure period of atrial fibrillation ablation.
Verma A; Tsang B
Curr Opin Cardiol; 2012 Jan; 27(1):55-61. PubMed ID: 22146378
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of therapeutic efficacy between fondaparinux and low molecular weight heparin for patients with acute coronary syndrome].
Wang QK; Guo M; Zhang YQ; Song Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Oct; 22(10):628-31. PubMed ID: 20977850
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.
Mardigyan V; Verma A; Birnie D; Guerra P; Redfearn D; Becker G; Champagne J; Sapp J; Gula L; Parkash R; Macle L; Crystal E; O'Hara G; Khaykin Y; Sturmer M; Veenhuyzen GD; Greiss I; Sarrazin JF; Mangat I; Novak P; Skanes A; Roux JF; Chauhan V; Hadjis T; Morillo CA; Essebag V
Can J Cardiol; 2013 Feb; 29(2):219-23. PubMed ID: 22840300
[TBL] [Abstract][Full Text] [Related]
37. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
[TBL] [Abstract][Full Text] [Related]
38. The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.
Deerhake JP; Merz JC; Cooper JV; Eagle KA; Fay WP
J Thromb Thrombolysis; 2007 Apr; 23(2):107-13. PubMed ID: 17221327
[TBL] [Abstract][Full Text] [Related]
39. Catheter ablation of left atrial arrhythmias on uninterrupted oral anticoagulation with vitamin K antagonists: What is the relationship between international normalized ratio, activated clotting time, and procedure-related complications?
Kottmaier M; Bourier F; Semmler V; Telishevska M; Koch-Büttner K; Lennerz C; Lengauer S; Kornmayer M; Rousseva E; Brooks S; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I; Reents T
J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1415-1422. PubMed ID: 28800176
[TBL] [Abstract][Full Text] [Related]
40. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.
Saad EB; d'Avila A; Costa IP; Aryana A; Slater C; Costa RE; Inácio LA; Maldonado P; Neto DM; Camiletti A; Camanho LE; Polanczyk CA
Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):615-21. PubMed ID: 21841192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]